Cargando…

Real world treatment sequences and outcomes for metastatic renal cell carcinoma

OBJECTIVES: The treatment landscape for metastatic renal cell carcinoma changed a lot in the last few years. This study aimed to assess the treatment sequences and outcomes for metastatic renal cell carcinoma in a real-world setting. MATERIALS AND METHODS: We enrolled patients with metastatic renal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Gu-Shun, Li, Jian-Ri, Wang, Shian-Shiang, Chen, Chuan-Shu, Yang, Chun-Kuang, Lin, Chia-Yen, Hung, Sheng-Chun, Chiu, Kun-Yuan, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664936/ https://www.ncbi.nlm.nih.gov/pubmed/37992086 http://dx.doi.org/10.1371/journal.pone.0294039

Ejemplares similares

Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics
por: Lin, Chia-Yen, et al.
Publicado: (2019)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
por: Hu, Ju-Chuan, et al.
Publicado: (2020)

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics
por: Hung, Sheng-Chun, et al.
Publicado: (2018)

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
por: Hu, Ju-Chuan, et al.
Publicado: (2021)

Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
por: Chang, Li-Wen, et al.
Publicado: (2021)

The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan
por: Chang, Li-Wen, et al.
Publicado: (2023)

Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy
por: Chang, Li-Wen, et al.
Publicado: (2023)

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
por: Chen, Chuan-Shu, et al.
Publicado: (2020)

Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Wang, Shian-Shiang, et al.
Publicado: (2013)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
por: Tsay, Ming-Dow, et al.
Publicado: (2019)

First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy
por: Hsieh, Hsiang-Chen, et al.
Publicado: (2022)

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
por: Yang, Cheng-Kuang, et al.
Publicado: (2023)

Impacts of AURKA Genetic Polymorphism on Urothelial Cell Carcinoma Development
por: Huang, Chia-Hung, et al.
Publicado: (2019)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study
por: Li, Jian-Ri, et al.
Publicado: (2022)

Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
por: Chiang, Tsung-Hsien, et al.
Publicado: (2022)

Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting
por: Yen, Hsu-Heng, et al.
Publicado: (2020)

Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2022)

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
por: Su, Yung-Yeh, et al.
Publicado: (2023)

Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia
por: Mei, Cheng-En, et al.
Publicado: (2022)

Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Weng, Wei-Chun, et al.
Publicado: (2020)

Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study
por: Su, Yung-Yeh, et al.
Publicado: (2022)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

The Association between Iron-Deficiency Anemia (IDA) and Septic Arthritis (SA): The Real-World Data
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study
por: Chen, Wei-Cheng, et al.
Publicado: (2023)

Hospice Care Improves Patients’ Self-Decision Making and Reduces Aggressiveness of End-of-Life Care for Advanced Cancer Patients
por: Wang, Chun-Li, et al.
Publicado: (2022)

Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma
por: Weng, Wei-Chun, et al.
Publicado: (2023)

Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
por: Kuo, Ming-Chun, et al.
Publicado: (2020)

Blockade of the N-Methyl-D-Aspartate Glutamate Receptor Ameliorates Lipopolysaccharide-Induced Renal Insufficiency
por: Lin, Chian-Shiung, et al.
Publicado: (2015)

Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features
por: Yu, Yung-Luen, et al.
Publicado: (2014)

Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study
por: Cheng, Wen-Chien, et al.
Publicado: (2023)

Incidence of Hip Fractures among Patients with Chronic Otitis Media: The Real-World Data
por: Liao, Pei-Shao, et al.
Publicado: (2022)

Clinical Factors Associated with Asymptomatic Women Having Inconclusive Screening Mammography Results: Experiences from a Single Medical Center in Taiwan
por: Wang, Chun-Li, et al.
Publicado: (2021)

Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population
por: Lee, Shou-Wu, et al.
Publicado: (2022)

When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: a real-world study from Taiwan
por: Chen, Chieh-Lung, et al.
Publicado: (2022)

Real-world Evidence of the Herb-drug Interactions
por: Pan, Hsueh-Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d07ehdcc5gnuqkej93n9ugq8sc